Protocol for the China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) Million Persons Project pilot

被引:129
作者
Lu, Jiapeng [1 ,2 ]
Xuan, Si [3 ,4 ]
Downing, Nicholas S. [3 ]
Wu, Chaoqun [1 ,2 ]
Li, Li [1 ,2 ]
Krumholz, Harlan M. [3 ,4 ,5 ]
Jiang, Lixin [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Natl Clin Res Ctr Cardiovasc Dis,Fuwai Hosp, Beijing 100730, Peoples R China
[2] Peking Union Med Coll, Beijing 100021, Peoples R China
[3] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA
[4] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA
[5] Yale Univ, Sch Med, Dept Internal Med, Robert Wood Johnson Clin Scholars Program,Sect Ca, New Haven, CT 06510 USA
关键词
CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; RISK-FACTOR; MYOCARDIAL-INFARCTION; LOWERING TREATMENT; CHOLESTEROL LEVELS; PHYSICAL-ACTIVITY; PREVALENCE; ADULTS; METAANALYSIS;
D O I
10.1136/bmjopen-2015-010200
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Collection of high-quality data from large populations is considered essential to generate knowledge that is critical to an era of precision medicine. Cardiovascular disease (CVD) is a leading cause of mortality in China and is a suitable focus of an initiative to discover factors that would improve our ability to assess and modify individual risk. Methods and analysis: The pilot phase of China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) Million Persons Project is being conducted during 2014-2015 in four provinces across China to demonstrate the feasibility of a population based assessment. It is designed to screen 0.4 million community-dwelling residents aged 40-75 years with measurements of blood pressure, height and weight, a lipid blood test, and a questionnaire on cardiovascular related health status. Participants identified at high risk of CVD receive further health assessments, including ECG, ultrasound scan, blood and urine analysis, and a questionnaire on lifestyle and medical history. Collection of blood and urine samples is used to establish a biobank. High-risk subjects are also counselled with suggestions regarding potential lifestyle changes. In addition, high-risk subjects are followed-up either in a return clinic visit or by telephone interview, with measurement of blood pressure, weight, ECG, and a questionnaire on survival status, hospitalisations and lifestyle. The first 0.1 million participants screened were used to conduct a preliminary analysis, with information on baseline characteristics, health-related behaviours, anthropometric variables, medical history, and prevalence of high-risk subjects. Ethics and dissemination: The central ethics committee at the China National Center for Cardiovascular Disease (NCCD) approved the pilot. Written informed consent is obtained from all participants on entry into the project. Findings will be disseminated in future peer-reviewed papers and will inform strategies aimed at developing precise methods of assessing and modifying risk.
引用
收藏
页数:14
相关论文
共 50 条
[41]   Population ageing challenges health care in China [J].
Wang, Xue-Qiang ;
Chen, Pei-Jie .
LANCET, 2014, 383 (9920) :870-870
[42]   Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China [J].
Wang, Y. ;
Mi, J. ;
Shan, X-y ;
Wang, Q. J. ;
Ge, K-y .
INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 (01) :177-188
[43]   Characteristics of High Risk People with Cardiovascular Disease in Chinese Rural Areas: Clinical Indictors, Disease Patterns and Drug Treatment [J].
Wei, Xiaolin ;
Zou, Guanyang ;
Yin, Jia ;
Walley, John ;
Zhou, Biao ;
Yu, Yunxian ;
Tian, Linwei ;
Chen, Kun .
PLOS ONE, 2013, 8 (01)
[44]  
World Health Organization/International Society of Hypertension, 2007, WHO ISH RISK PRED CH
[45]  
World Health Organization (WHO), 2007, Prevention of Cardiovascular Disease: Guidelines for Assessment and Management of Total Cardiovascular Risk
[46]   Prevalence, Awareness, Treatment, and Control of Hypertension in China Data from the China National Nutrition and Health Survey 2002 [J].
Wu, Yangfeng ;
Huxley, Rachel ;
Li, Liming ;
Anna, Vibeke ;
Xie, Gaoqiang ;
Yao, Chonghua ;
Woodward, Mark ;
Li, Xian ;
Chalmers, John ;
Gao, Runlin ;
Kong, Lingzhi ;
Yang, Xiaoguang .
CIRCULATION, 2008, 118 (25) :2679-2686
[47]   Prevalence and Control of Diabetes in Chinese Adults [J].
Xu, Yu ;
Wang, Limin ;
He, Jiang ;
Bi, Yufang ;
Li, Mian ;
Wang, Tiange ;
Wang, Linhong ;
Jiang, Yong ;
Dai, Meng ;
Lu, Jieli ;
Xu, Min ;
Li, Yichong ;
Hu, Nan ;
Li, Jianhong ;
Mi, Shengquan ;
Chen, Chung-Shiuan ;
Li, Guangwei ;
Mu, Yiming ;
Zhao, Jiajun ;
Kong, Lingzhi ;
Chen, Jialun ;
Lai, Shenghan ;
Wang, Weiqing ;
Zhao, Wenhua ;
Ning, Guang .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (09) :948-958
[48]   Smoking in China - Findings of the 1996 National Prevalence Survey [J].
Yang, GH ;
Fan, LX ;
Tan, J ;
Qi, GM ;
Zhang, YF ;
Samet, JM ;
Taylor, CE ;
Becker, K ;
Xu, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (13) :1247-1253
[49]   Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007-2008 China National Diabetes and Metabolic Disorders Study [J].
Yang, Zhao-Ju ;
Liu, Jie ;
Ge, Jia-Pu ;
Chen, Li ;
Zhao, Zhi-Gang ;
Yang, Wen-Ying .
EUROPEAN HEART JOURNAL, 2012, 33 (02) :213-220
[50]  
Yu-Poth S, 1999, AM J CLIN NUTR, V69, P632